Tasigna Cancer Medication Lawsuits

Manufactured by Korean multinational pharmaceutical firm Novartis International AG, Tasigna is an oral treatment cancer medication used to treat patients with leukemia. The drug is very popular, having made $4.7 billion in global sales in 2015 alone.

Image Source: Google

Hospital despite its own popularity and widespread usage, the security of Tasigna has been called into question by many of lawsuits linking it into serious complications.

In addition, a clinical trial reported from the National Cancer Institute that discovered that the medication caused adverse side effects in over 98 percent of individuals.

Should you or someone you love suffered severe side effects or complications while choosing Tasigna, then you might qualify for compensation by Tasigna attorney in St. Louis. Here is what you want to understand whether you're thinking about submitting a Tasigna dangerous medication suit.

Around Tasigna

CML is a cancerous advanced cancer where an abnormal Philadelphia chromosome creates too many white blood cells, preventing healthy tissues from working correctly.

The U.S. Food and Drug Administration (FDA) first approved Tasigna at October 2007 for treating CML in elderly patients resistant or intolerant to previous treatments that comprised Gleevec® (imatinib).

In June 2010, the FDA also accepted Tasigna as a remedy for patients diagnosed with CML. Furthermore, at December 2017, the FDA upgraded Tasigna's tag to signify that some CML patients could have the ability to stop treatment following a sustained reaction.


Leave a Reply

Your email address will not be published. Required fields are marked *